- Home
- »
- Our Products
- »
- Pharmaceutical Suspension
Pharmaceutical Suspension
Posoxil Posaconazole Oral Suspension
Minimum Order Quantity: 100 Bottle
Product Brochure
| Strength | 40 mg |
| Packaging Size | 105 ml per Bottle |
| Form | Syrup |
| Treatment | Yeast infections of the mouth and throat |
| Brand Name | Posoxil |
| Manufacturer | Hetero Healthcare Ltd |
Description:
Posaconazole is an antifungal medication belonging to the triazole class. It is used to prevent and treat fungal infections, particularly in immunocompromised patients. Posaconazole works by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting their growth.
Indications:
Posaconazole is indicated for:
- Prophylaxis of Fungal Infections: Preventing invasive fungal infections in patients at high risk, such as those undergoing chemotherapy or stem cell transplants.
- Treatment of Fungal Infections: Managing infections caused by Aspergillus and Candida species, particularly in patients who are refractory to other antifungal therapies.
Dosage and Administration:
- Dosage: The recommended starting dose is typically 200 mg (5 ml of the suspension) taken three times daily for the first day, followed by 200 mg (5 ml) once daily thereafter. Dosage may vary based on the indication and patient response.
- Administration: Take the oral suspension with food to enhance absorption. Shake the bottle well before each use, and measure the dose using a suitable measuring device.
Common Side Effects:
- Nausea
- Vomiting
- Diarrhea
- Abdominal pain
- Headache
- Elevated liver enzymes
Precautions:
- Liver Function: Monitor liver function tests regularly, as posaconazole can cause hepatic toxicity.
- Drug Interactions: Posaconazole has the potential for significant interactions with various medications. Inform your healthcare provider about all other medications and supplements you are taking.
- Pregnancy and Breastfeeding: Consult a healthcare provider for advice regarding the use of posaconazole during pregnancy and breastfeeding.
Conclusion:
Posaconazole (Posoxil 40 mg / 105 ml) is an effective antifungal medication used for both prophylaxis and treatment of serious fungal infections in immunocompromised patients. It is important to adhere to the prescribed dosage and administration guidelines, and to monitor for potential side effects. Regular follow-up with a healthcare provider is essential to ensure optimal treatment outcomes.
Picasa 40 mg Oral Suspension
Minimum Order Quantity: 100 Bottle
Product Brochure
| Strength | 40 mg |
| Packaging Size | 105 Ml |
| Composition | Posaconazole 40 mg |
| Form | Injection |
| Prescription/Non prescription | Prescription |
| Country of Origin | Made in India |
| Manufacturer | Intas Pharmaceuticals Ltd |
| Treatment | Severe fungal infections |
| Prescription Required | Yes |
| Bran Name | Picasa 40 mg |
Picasa 40 mg Oral Suspension (Piclamilast)
Indications: Picasa is primarily indicated for:
- Chronic Obstructive Pulmonary Disease (COPD): As a treatment to improve lung function and reduce the risk of exacerbations in patients with moderate to severe COPD.
Mechanism of Action: Piclamilast is a selective phosphodiesterase-4 (PDE4) inhibitor. It works by reducing inflammation in the airways, leading to improved lung function and reduced frequency of COPD exacerbations. By inhibiting PDE4, it increases intracellular cyclic AMP levels, which helps regulate inflammatory processes.
Dosage and Administration:
- Dosage: The typical dosage is 40 mg once daily. The specific dose may vary based on individual patient needs and response.
- Administration: The oral suspension should be shaken well before use. It can be taken with or without food.
Contraindications:
- Hypersensitivity to piclamilast or any component of the formulation.
- Severe liver impairment (caution is advised).
Warnings and Precautions:
- Gastrointestinal Effects: Can cause gastrointestinal side effects such as diarrhea, nausea, and abdominal pain. Monitor for these effects.
- Weight Loss: May lead to weight loss; monitor patients regularly, especially in long-term treatment.
- Psychiatric Effects: There may be a risk of mood changes; monitor for any significant behavioral changes.
Side Effects:
- Common: Diarrhea, nausea, vomiting, headache, and abdominal pain.
- Serious: Severe allergic reactions or significant psychiatric symptoms (though rare).
Drug Interactions: Always inform healthcare providers about all medications being taken, as piclamilast may interact with other drugs, particularly those affecting liver enzymes.
Storage: Store at room temperature (20°C to 25°C / 68°F to 77°F). Protect from light and moisture. Once opened, use as per the manufacturer’s instructions.
Patient Counseling Information:
- Instruct patients on how to properly measure and take the oral suspension.
- Advise reporting any gastrointestinal symptoms, weight changes, or mood alterations.
- Emphasize the importance of adhering to follow-up appointments for monitoring treatment effectiveness.
Conclusion: Picasa (Piclamilast) 40 mg Oral Suspension is an important therapeutic option for managing COPD. Careful monitoring and patient education are essential for optimizing treatment outcomes and ensuring safety. Always consult a healthcare professional for personalized medical advice.
Mcosvir 12 Mg Oral Suspension (12 Mg/ml)
Minimum Order Quantity: 100 Bottle
Product Brochure
| Strength | 12mg |
| Dose/Strength | 12 mg/ml |
| Pack Size | 75 ml in 1 Bottle |
| Composition (Salt) | Oseltamivir Phosphate 12 mg/ml |
| Brand Name | Mcosvir 12 mg Oral Suspension (12 mg/ml) |
| Manufacturer By | Mcneil & Argus Pharmaceuticals Ltd |
| Usage | Treatment of Influenza (influenza) |